The continuous bioprocessing market refers to the production and manufacturing of biologic products such as proteins, vaccines, and monoclonal antibodies using continuous, rather than batch, processing techniques. Continuous bioprocessing allows for more efficient production, offering advantages such as increased productivity, lower operating costs, and consistent product quality. The market includes various technologies and equipment used to implement continuous bioprocesses, such as bioreactors, filtration systems, and sensors for real-time monitoring.